Stock CTNM CONTINEUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Contineum Therapeutics, Inc.

Equities

CTNM

US21217B1008

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
19.93 USD +3.86% Intraday chart for Contineum Therapeutics, Inc. +4.62% 0.00%
24/06 Contineum Therapeutics, Inc. Appoints Sarah Boyce as Independent Member of its Board of Directors CI
24/06 Contineum Therapeutics, Inc.(NasdaqGS:CTNM) added to S&P TMI Index CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Contineum Therapeutics, Inc. Appoints John Healy as General Counsel & Corporate Secretary
CI
Contineum Therapeutics, Inc. Appoints Troy Ignelzi as Independent Member of Its Board of Directors and as Chair of the Audit Committee
CI
Sector Update: Health Care Stocks Rise Late Afternoon
MT
Sector Update: Health Care
MT
Contineum Therapeutics' Shares Fall After IPO Pricing
MT
Contineum Therapeutics Prices IPO at $16 a Share
MT
Contineum Therapeutics, Inc. has completed an IPO in the amount of $110 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTNM Stock
  4. News Contineum Therapeutics, Inc.
  5. Highlights